How painkillers can contribute to anemia in cancer patients
A recent study reveals a surprising connection between common painkillers and anemia in cancer patients. Researchers from the German Cancer Research Center and the University of Freiburg have discovered that painkillers like diclofenac and acetaminophen, widely used for their anti-inflammatory and pain-relieving properties, can inadvertently disrupt iron metabolism in liver cancer cells. This disruption leads to iron deficiency and anemia, which are common complications in cancer patients.
The study, led by Ursula Klingmüller and Jens Timmer, found that these painkillers, while reducing inflammation, significantly increase the production of the iron-regulating hormone hepcidin in liver cancer cells. Hepcidin, which normally helps regulate iron levels, can cause excessive iron retention in the body, leading to anemia when present in high amounts. This finding highlights a potential unintended side effect of these commonly prescribed medications.
Using advanced proteome analyses and mathematical modeling, the team identified that the drugs alter the activity of specific signaling pathways, particularly the IL-6 and BMP pathways, which control hepcidin production. This effect was not observed in healthy liver cells, indicating a targeted impact on cancer cells.
The research opens up new possibilities for personalized pain therapy in cancer patients, who often suffer from iron deficiency anemia. By inhibiting the BMP receptor, the study suggests, it may be possible to prevent the undesirable increase in hepcidin, thereby reducing the risk of iron deficiency and therapy-related anemia.
This groundbreaking study, conducted in collaboration between the DKFZ, Heidelberg University, Heidelberg University Hospital, Leipzig University Hospital, and the University of Freiburg, emphasizes the importance of understanding the complex interactions between cancer, pain management, and nutritional deficiencies. Further research is needed to explore these findings and their implications for patient care.
